Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
71,516.16
(
-2.14%
)
News Focus
News Focus

Replies to post #250519 on Biotech Values

Replies to #250519 on Biotech Values
icon url

tony111

02/05/24 9:54 PM

#250520 RE: DewDiligence #250519

25M for tafasitamab is a pretty good deal. Consider if tafasitamab is successful in first line DLBCL and second line lymphoma, INCY will have to pay MOR 500M in milestone.